Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Oct 8:9:150.
doi: 10.1186/s13012-014-0150-8.

The roles and influence of actors in the uptake of evidence: the case of malaria treatment policy change in Uganda

Juliet Nabyonga-Orem  1 , Miriam Nanyunja, Bruno Marchal, Bart Criel, Freddie Ssengooba
Affiliations

The roles and influence of actors in the uptake of evidence: the case of malaria treatment policy change in Uganda

Juliet Nabyonga-Orem et al. Implement Sci. .

Abstract

Background: Uganda changed its malaria treatment policy in response to evidence of resistance to commonly used antimalarials. The use of evidence in policy development--also referred to as knowledge translation (KT)--is crucial, especially in resource-limited settings. However, KT processes occur amidst a complex web of stakeholder interactions. Stakeholder involvement in evidence generation and in KT activities is essential. In the present study, we explored how stakeholders impacted the uptake of evidence in the malaria treatment policy change in Uganda.

Methods: We employed a qualitative case study methodology involving interviews with key informants and review of documents. A timeline of events was developed, which guided the purposive sampling of respondents and identification of relevant documents. Data were analysed using inductive content analysis techniques.

Results: Stakeholders played multiple roles in evidence uptake in the malaria treatment policy change. Donors, the Ministry of Health (MoH), service providers, and researchers engaged in the role of evidence generation. The MoH, parliamentarians, and opinion leaders at the national and local levels engaged in dissemination of evidence. The donors, MoH, researchers, and service providers engaged in the uptake of evidence in policy development and implementation. Stakeholders exerted varying levels of support and influence for different reasons. It is noteworthy that all of the influential stakeholders were divided regarding the best antimalarial alternative to adopt.

Conclusion: Our results showed a diverse group of stakeholders who played multiple roles, with varying levels of support and influence on the uptake of evidence in the malaria treatment policy change. For a given KT processes, mapping the relevant stakeholders and devising mechanism for their engagement and for how to resolve conflicts of interest and disagreements a priori will enhance uptake of evidence in policy development.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Process, timelines, and stakeholders involved in the malaria treatment policy change.
Figure 2
Figure 2
Support and influence of the different stakeholders involved in the malaria treatment policy change.
See this image and copyright information in PMC

References

    1. Kamya MR, Bakyaita NN, Talisuna AO, Were WM, Staedke SG. Increasing antimalarial drug resistance in Uganda and revision of the national drug policy. Trop Med Int Health. 2002;7(12):1031–1041. doi: 10.1046/j.1365-3156.2002.00974.x. - DOI - PubMed
    1. The efficacy of antimalarial monotherapies, sulphadoxine-pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop Med Int Health. 2003, 8 (10): 860-867. 10.1046/j.1360-2276.2003.01114.x. - PubMed
    1. Framework for Developing, Implementing, and Updating Antimalaria Treatment Policy: A Guide for Country Malaria Control Programmes. 2003, World Health Organization Regional Office for Africa, Brazzaville
    1. Mori AT, Kaale EA, Ngalesoni F, Norheim OF, Robberstad B. The role of evidence in the decision-making process of selecting essential medicines in developing countries: the case of Tanzania. PLoS One. 2014;9(1):e84824. doi: 10.1371/journal.pone.0084824. - DOI - PMC - PubMed
    1. Turner P, Whitfield TW. Physiotherapists’ use of evidence based practice: a cross-national study. Physiother Res Int. 1997;2(1):17–29. doi: 10.1002/pri.76. - DOI - PubMed

Publication types